1. Home
  2. VCYT

VCYT

Veracyte Inc.

as 03-31-2025 3:45pm EST

$
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
-
$
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
-
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
%

Stocks

Health Care

Medical Specialities

Nasdaq

;SMA (50)$37.34EMA (200)$34.26O: $29.24 H: $29.95 L: $28.52 C: $29.87 +0.63 (+2.15%)Elder Ray −1.50, −2.93
Founded: 2006 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: N/A IPO Year: 2013
Target Price: $42.67 AVG Volume (30 days): 938.6K
Analyst Decision: Buy Number of Analysts: 9
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.31 EPS Growth: N/A
52 Week Low/High: $18.61 - $47.32 Next Earning Date: 05-06-2025
Revenue: $445,764,000 Revenue Growth: 23.46%
Revenue Growth (this year): 11.7% Revenue Growth (next year): 11.03%

VCYT Daily Stock ML Predictions

SELLHOLDBUYas of 18 hours ago

Stock Insider Trading Activity of Veracyte Inc. (VCYT)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Leite John VCYT Chief Commercial Officer-CLIA Mar 6 '25 Sell $31.50 7,411 $234,629.55 100,249
Stapley Marc VCYT Chief Executive Officer Mar 4 '25 Sell $33.70 52,697 $1,756,855.23 269,129
McGuire Annie VCYT SVP, General Counsel Mar 4 '25 Sell $33.69 1,142 $38,476.49 70,308
Febbo Phillip G. VCYT Chief Scientific & Med Officer Mar 4 '25 Sell $33.41 8,037 $268,012.94 86,110
Leite John VCYT Chief Commercial Officer-CLIA Feb 27 '25 Sell $33.84 5,746 $194,444.64 100,249
Chambers Rebecca VCYT Chief Financial Officer Feb 3 '25 Sell $43.85 527 $23,108.95 113,510
EASTHAM KARIN VCYT Director Jan 2 '25 Sell $40.31 10,000 $403,005.64 18,497

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use